Heparin induced thrombocytopenia antibodies in Covid-19.
作者信息
Patell Rushad, Khan Adeel M, Bogue Thomas, Merrill Mwanasha, Koshy Anita, Bindal Poorva, Joyce Robin, Aird William C, Neuberg Donna, Bauer Kenneth A, Zwicker Jeffrey I
机构信息
Division of Hematology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
出版信息
Am J Hematol. 2020 Oct;95(10):E295-E296. doi: 10.1002/ajh.25935. Epub 2020 Aug 8.
Abstract
摘要
相似文献
1
Heparin induced thrombocytopenia antibodies in Covid-19.新冠病毒感染中肝素诱导的血小板减少抗体
Am J Hematol. 2020 Oct;95(10):E295-E296. doi: 10.1002/ajh.25935. Epub 2020 Aug 8.
2
Serotonin Release Assay: Functional Assay for Heparin- and Vaccine-Induced (Immune) Thrombotic Thrombocytopenia.血清素释放试验：肝素和疫苗诱导的（免疫性）血栓性血小板减少症的功能检测。
Methods Mol Biol. 2023;2663:463-477. doi: 10.1007/978-1-0716-3175-1_30.
3
Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban.在患有Ⅱ型肝素诱导的血小板减少症和肾功能损害的患者进行体外循环期间，使用肝素和血小板糖蛋白IIb-IIIa拮抗剂替罗非班进行抗凝。
Anesthesiology. 2001 Feb;94(2):245-51. doi: 10.1097/00000542-200102000-00013.
4
The complicated relationships of heparin-induced thrombocytopenia and platelet factor 4 antibodies with COVID-19.肝素诱导的血小板减少症和血小板因子 4 抗体与 COVID-19 的复杂关系。
Int J Lab Hematol. 2021 Aug;43(4):547-558. doi: 10.1111/ijlh.13582. Epub 2021 May 17.
5
A case of severe COVID-19 with pulmonary thromboembolism related to heparin-induced thrombocytopenia during prophylactic anticoagulation therapy.COVID-19 严重病例，在预防性抗凝治疗期间因肝素诱导的血小板减少症并发肺血栓栓塞症。
J Infect Chemother. 2022 Aug;28(8):1208-1211. doi: 10.1016/j.jiac.2022.05.001. Epub 2022 May 11.
6
Heparin-Induced Thrombocytopenia in COVID-19.新型冠状病毒肺炎中的肝素诱导的血小板减少症
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620944091. doi: 10.1177/2324709620944091.
7
Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia.在疑似肝素诱导血小板减少症的危重症 COVID-19 患者中鉴定出血小板激活免疫复合物。
J Thromb Haemost. 2021 May;19(5):1342-1347. doi: 10.1111/jth.15283. Epub 2021 Mar 14.
8
Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia.自发性 HIT 综合征：膝关节置换术、感染，与疫苗诱导的免疫性血栓性血小板减少症的相似之处。
Thromb Res. 2021 Aug;204:40-51. doi: 10.1016/j.thromres.2021.05.018. Epub 2021 Jun 9.
9
Ischemic Stroke and Bilateral Pulmonary Embolism in COVID-19: COVID-Associated Coagulopathy or Heparin-Induced Thrombocytopenia.新型冠状病毒肺炎相关的缺血性中风和双侧肺栓塞：新冠相关凝血病还是肝素诱导的血小板减少症
J Hematol. 2022 Feb;11(1):40-44. doi: 10.14740/jh956. Epub 2022 Feb 26.
10
The potential impact of Covid-19 on the capacity of routine laboratory tests to detect heparin-induced thrombocytopenia.新冠病毒病（Covid-19）对常规实验室检测肝素诱导的血小板减少症能力的潜在影响。
Thromb J. 2022 Sep 26;20(1):55. doi: 10.1186/s12959-022-00411-0.
引用本文的文献
1
Prothrombotic antibodies targeting the spike protein's receptor-binding domain in severe COVID-19.针对重症 COVID-19 中刺突蛋白受体结合域的促血栓形成抗体。
Blood. 2025 Feb 6;145(6):635-647. doi: 10.1182/blood.2024025010.
2
Anticoagulant therapy in COVID-19: A narrative review.新型冠状病毒肺炎的抗凝治疗：叙述性综述。
Clin Transl Sci. 2023 Sep;16(9):1510-1525. doi: 10.1111/cts.13569. Epub 2023 Jun 30.
3
Significance of heparin induced thrombocytopenia (HIT) in COVID-19: a systematic review and meta-analysis.肝素诱导的血小板减少症（HIT）在 COVID-19 中的意义：系统评价和荟萃分析。
J Thromb Thrombolysis. 2023 Aug;56(2):241-252. doi: 10.1007/s11239-023-02827-5. Epub 2023 May 23.
4
Use of fondaparinux in patients with heparin-induced thrombocytopenia on veno-venous extracorporeal membrane oxygenation: A three-patient case series report.磺达肝癸钠在接受静脉-静脉体外膜肺氧合治疗的肝素诱导的血小板减少症患者中的应用：三例病例系列报告
Front Med (Lausanne). 2023 Feb 23;10:1112770. doi: 10.3389/fmed.2023.1112770. eCollection 2023.
5
Prevalence and clinical implication of thrombocytopenia and heparin-induced thrombocytopenia in patients who are critically ill with COVID-19.COVID-19 重症患者血小板减少症和肝素诱导的血小板减少症的患病率及其临床意义。
Clin Med (Lond). 2022 Sep;22(5):403-408. doi: 10.7861/clinmed.2022-0054.
6
Coronavirus Disease 2019-Associated Coagulopathy.2019冠状病毒病相关凝血病
Microorganisms. 2022 Aug 2;10(8):1556. doi: 10.3390/microorganisms10081556.
7
Hematological manifestations of COVID-19 acute respiratory distress syndrome patients and the impact of thrombocytopenia on disease outcomes: A retrospective study.新型冠状病毒肺炎急性呼吸窘迫综合征患者的血液学表现及血小板减少对疾病预后的影响：一项回顾性研究
Int J Crit Illn Inj Sci. 2022 Apr-Jun;12(2):95-100. doi: 10.4103/ijciis.ijciis_96_21. Epub 2022 Jun 24.
8
Ischemic Stroke Due to Heparin-induced Thrombocytopenia during Severe COVID-19 Infection.严重 COVID-19 感染期间肝素诱导的血小板减少症导致的缺血性脑卒中。
Intern Med. 2022 Sep 15;61(18):2797-2801. doi: 10.2169/internalmedicine.9531-22. Epub 2022 Jul 5.
9
Accelerated heparin-induced thrombocytopenia in a COVID-19 patient; a case report with literature review.一名新冠肺炎患者出现加速型肝素诱导的血小板减少症；病例报告及文献综述
Ann Med Surg (Lond). 2022 Jun;78:103749. doi: 10.1016/j.amsu.2022.103749. Epub 2022 May 11.
10
Heparin-Induced Thrombocytopenia in COVID-19: A Systematic Review.新型冠状病毒肺炎中的肝素诱导的血小板减少症：一项系统评价
Anesth Essays Res. 2021 Oct-Dec;15(4):341-347. doi: 10.4103/aer.aer_151_21. Epub 2022 Mar 8.
Zotero 插件